The anti-malaria drug hydroxychloroquine has been working in COVID-19 patients, Secretary of Veterans Affairs Robert Wilkie said on Wednesday.
Wilkie’s comments come after a study looking at the effects of the drug in 368 patients in Veterans Health Administration hospitals found no evidence the drug is effective against COVID-19, a new disease caused by the CCP (Chinese Communist Party) virus.
